Reduced levels of protein-bound ceramides at 6 weeks were associated with an increased risk of atopic dermatitis by age 1 year, according to a new study in JACI.
A genome-wide meta-analysis identified novel genetic interactions between ERAP1 and MHC class I alleles, highlighting their role in frontal fibrosing alopecia susceptibility.
A 62-year-old female developed fixed drug eruption following semaglutide administration, highlighting the importance of recognizing unusual dermatologic reactions during treatment with glucagon-like peptide-1 receptor agonists.
FDA grants IND clearance to Zabalafin Hydrogel, a botanical drug targeting bacterial, inflammatory, and pruritic components of atopic dermatitis, following successful Phase 2a trials.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Researchers examined systemic absorption, metabolism, and excretion of tattoo ink tracers, providing evidence for a cutaneous first-pass effect and measuring systemic exposure levels.
Researchers found that benzene formation in benzoyl peroxide products is influenced by formulation factors, with hot processing increasing levels and antioxidants reducing them.